Benzenesulfonamides and benzamides as therapeutic agents
JC Medina - US Patent 6,583,161, 2003 - Google Patents
States. The disease results from exceSS cholesterol accumu lation in the arterial walls,
which forms plaques that inhibit blood flow and promote clot formation, ultimately causing …
which forms plaques that inhibit blood flow and promote clot formation, ultimately causing …
Benzenesulfonamides and benzamides as therapeutic agents
JC Medina - US Patent 6,191,170, 2001 - Google Patents
Atherosclerosis is a leading cause of death in the United States. The disease results from
excess cholesterol accumu lation in the arterial Walls, Which forms plaques that inhibit blood …
excess cholesterol accumu lation in the arterial Walls, Which forms plaques that inhibit blood …
Compositions of Allosteric Hemoglobin Modifiers and Methods of Making the Same
A Quick, A Santos, AJG Carvalho… - US Patent App. 10 …, 2007 - Google Patents
The present invention provides novel compositions of allos teric hemoglobin modifiers which
are substantially free of impurities, specifically polymeric impurities. In one embodiment, the …
are substantially free of impurities, specifically polymeric impurities. In one embodiment, the …
Medical uses of allosteric hemoglobin modifier compounds in patient care
DJ Abraham, M Gerber - US Patent 5,677,330, 1997 - Google Patents
57 ABSTRACT A family of compounds has been found to be useful for right-shifting
hemoglobin towards a low oxygen affinity state. The effect has particular application in a …
hemoglobin towards a low oxygen affinity state. The effect has particular application in a …
Preparation and use of a stable formulation of allosteric effector compounds
DG Johnson, M Doty, JE Kipp - 2003 - Google Patents
WO2003086324A2 - Preparation and use of a stable formulation of allosteric effector
compounds - Google Patents WO2003086324A2 - Preparation and use of a stable …
compounds - Google Patents WO2003086324A2 - Preparation and use of a stable …
Allosteric hemoglobin modifiers to decrease oxygen affinity in blood
DJ Abraham, M Mahran, A Mehanna… - US Patent …, 1995 - Google Patents
2005-03-23 Assigned to VIRGINIA COMMONWEALTH UNIVERSITY INTELLECTUAL
PROPERTY FOUNDATION reassignment VIRGINIA COMMONWEALTH UNIVERSITY …
PROPERTY FOUNDATION reassignment VIRGINIA COMMONWEALTH UNIVERSITY …
Use of allosteric hemoglobin modifiers in combination with radiation therapy to treat carcinogenic tumors
DJ Abraham - US Patent 5,705,521, 1998 - Google Patents
[57] ABSTRACT A family of compounds has been found to be useful for right-shifting
hemoglobin towards a low oxygen affinity state. The effect has particular application in …
hemoglobin towards a low oxygen affinity state. The effect has particular application in …
Allosteric modifiers of hemoglobin
DJ Abraham, M Gerber - US Patent 5,927,283, 1999 - Google Patents
30, 1993, Pat. No. 5,432,191, which is a continuation-in-part Attorney, Agent, or Firm
Whitham, Curtis & Whitham of application No. 08/006,246, Jan. 19, 1993, Pat. No …
Whitham, Curtis & Whitham of application No. 08/006,246, Jan. 19, 1993, Pat. No …
Indole-and benzimidazole amides as hydroxysteroid dehydrogenase inhibitors
JP Kilburn, HS Andersen, GCT Kampen - US Patent 8,153,798, 2012 - Google Patents
US PATENT DOCUMENTS 2.913, 454 A 11, 1959 Petersen et al. 3,723.442 A 3, 1973
Nakanishi et al. 3,784,551 A 1/1974 Nakanishi et al. 4,350,696 A 9, 1982 Cross et al …
Nakanishi et al. 3,784,551 A 1/1974 Nakanishi et al. 4,350,696 A 9, 1982 Cross et al …
Pharmaceutical use of substituted amides
JP Kilburn, HS Andersen, GCT Kampen… - US Patent …, 2011 - Google Patents
The use of substituted amides for modulating the activity of 11-hydroxysteroid
dehydrogenase type 1 (11 HSD1) and the use of these compounds as pharmaceutical …
dehydrogenase type 1 (11 HSD1) and the use of these compounds as pharmaceutical …